SCHOLAR ROCK HLDG CORP's ticker is SRRK and the CUSIP is 80706P103. A total of 85 filers reported holding SCHOLAR ROCK HLDG CORP in Q2 2022. The put-call ratio across all filers is 0.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $141,480 | +74.7% | 17,685 | +19.4% | 0.00% | – |
| Q2 2022 | $81,000 | -61.6% | 14,815 | +74.4% | 0.00% | -100.0% |
| Q4 2021 | $211,000 | -63.2% | 8,496 | -57.2% | 0.00% | -50.0% |
| Q2 2021 | $574,000 | -63.8% | 19,857 | -36.6% | 0.00% | -77.8% |
| Q1 2021 | $1,586,000 | +283.1% | 31,310 | +267.4% | 0.01% | +200.0% |
| Q4 2020 | $414,000 | +42.8% | 8,522 | -48.1% | 0.00% | -25.0% |
| Q3 2020 | $290,000 | -52.0% | 16,414 | -50.5% | 0.00% | -60.0% |
| Q2 2020 | $604,000 | +9.8% | 33,167 | -26.9% | 0.01% | -28.6% |
| Q1 2020 | $550,000 | -20.5% | 45,378 | -13.6% | 0.01% | +250.0% |
| Q4 2019 | $692,000 | -2.8% | 52,522 | -34.0% | 0.00% | -33.3% |
| Q3 2019 | $712,000 | -26.1% | 79,528 | +30.8% | 0.01% | -33.3% |
| Q2 2019 | $964,000 | +49.5% | 60,789 | +77.0% | 0.01% | +28.6% |
| Q1 2019 | $645,000 | – | 34,336 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Artal Group S.A. | 2,450,000 | $31,581,000 | 1.32% |
| Logos Global Management LP | 675,000 | $8,701,000 | 1.13% |
| Samsara BioCapital, LLC | 339,611 | $4,378,000 | 1.10% |
| Redmile Group, LLC | 2,407,326 | $31,030,000 | 0.97% |
| Bellevue Group AG | 2,184,425 | $28,157,000 | 0.33% |
| Frazier Life Sciences Management, L.P. | 156,000 | $2,011,000 | 0.17% |
| Atom Investors LP | 25,839 | $333,000 | 0.16% |
| GSA CAPITAL PARTNERS LLP | 32,010 | $413,000 | 0.06% |
| Tekla Capital Management LLC | 108,833 | $1,403,000 | 0.05% |
| Virtus ETF Advisers LLC | 6,212 | $80,000 | 0.04% |